Caris Life Sciences, Inc. (CAI) Price Prediction & ForecastCAICaris Life Sciences, Inc.

Alphio's CAI stock price prediction model matches the current Caris Life Sciences, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $30.68 (+0.39%). The 1-week path is $32.71 (+7.04%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Caris Life Sciences Inc is a good buy right now due to its current price of $29.7, which is below several analyst price targets, including $35 from BofA. The company has shown strong revenue growth, with Q2 2026 revenue of $263.7 million representing a 45.4% year-over-year increase. Additionally, the stock's RSI is at 55.86, indicating a neutral momentum, and it has recently experienced a 5-day change of +4.95%. However, a risk to consider is the high forward P/E ratio of 43.29, suggesting that the stock may be overvalued if growth does not meet expectations.

Caris Life Sciences, Inc. (CAI) last closed at $30.56, losing -3.78%. These facts feed the 1-day and 1-week CAI price prediction above.